Form 8-K

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): August 12, 2003

 

AMEDISYS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

(State or Other Jurisdiction of

Incorporation or Organization)

 

0-24260   11-3131700
(Commission File Number)   (I.R.S. Employer Identification No.)

 

11100 Mead Road, Suite 300, Baton Rouge, LA 70816

(Address of principal executive offices including zip code)

 

(225) 292-2031

(Registrant’s telephone number, including area code)

 



ITEM 7.    FINANCIAL STATEMENTS AND EXHIBITS

 

(a)

 

Financial Statements of Business Acquired.

   

Not applicable.

(b)

 

Pro Forma Financial Information.

   

Not applicable.

(c)  

Exhibit
No.


    
   

32.1 (i)

   Certification of William F. Borne, Chief Executive Officer
   

32.2 (i)

   Certification of Gregory H. Browne, Chief Financial Officer
   

99.1 (i)

  

Press Release dated August 12, 2003 announcing the Company’s second quarter 2003 operating results

        

(i)    Filed herewith.

 

ITEM 9.    REGULATION FD DISCLOSURE

 

On August 12, 2003, Amedisys, Inc., “the Company”, issued a press release attached hereto as Exhibit 99.1 releasing second quarter 2003 operating results.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AMEDISYS, INC.

By:

 

/s/    Gregory H. Browne

   
    Gregory H. Browne
    Chief Financial Officer
    DATE: August 12, 2003